Industry & Business

Diaceutics is Developing a Data Science Platform in Belfast to Improve Patient Diagnostic Testing Globally

 Breaking News
  • Fáilte Ireland Unveils Range of Measures to Sustain Tourism Growth For 2019 Creating a series of long-term tourism development plans for specific geographical locations, developing new festivals to lengthen the tourism season, and promoting careers in the tourism sector – these are just some of the key initiatives Fáilte Ireland’s CEO Paul Kelly has outline, as he set out plans for 2019. As the tourism agency looks to [...]...
  • Genesys Creates 200 New Tech Jobs and Establishes Global Artificial Intelligence Centre of Excellence Genesys®, the global leader in omnichannel customer experience and contact centre solutions, has announced it is creating 200 new technology jobs in Ireland over the next three years. The senior and highly skilled technical roles are based at the company’s new Galway office. The state-of-the-art facility serves as a Genesys research and development (R&D) hub [...]...
  • Bausch Health to Expand Contact Lens Manufacturing Facility in Waterford Bausch Health Companies will invest to expand contact lens manufacturing capacity at its Bausch + Lomb sites in Waterford, Ireland and Rochester in the US. The company is adding multiple production lines at these two sites to support the manufacture of its innovative daily disposable silicone hydrogel (SiHy daily) contact lenses. “Bausch + Lomb is one [...]...
  • PropertyBridges.com Successfully Completes First Ever Peer to Peer Property Loan in Ireland Propertybridges.com, Ireland’s new peer to peer lender to the property development marketplace, has just successfully fulfilled its first loan. Over 100 lenders piled into the 250k loan for a new mews build in Sandycove, County Dublin and supported the small developer as well as made 8.5% return for themselves. The whole process took less than [...]...
  • Inclusive and Sustainable Responsible Research & Innovation More citizens are involved in science through public engagement. Natural scientists and social scientists have formed collaborations. Users are leading innovation. Open access trends are changing the publishing system. Gender equality has gained political momentum. Together, these efforts form a European-wide approach called Responsible Research and Innovation (RRI). It implies that all of society (researchers, [...]...

Diaceutics is Developing a Data Science Platform in Belfast to Improve Patient Diagnostic Testing Globally

Diaceutics is Developing a Data Science Platform in Belfast to Improve Patient Diagnostic Testing Globally
October 26
12:20 2018

Precision Medicine and diagnostics commercialisation service provider, Diaceutics, is investing £2 million in R&D to create a new data platform leveraging data from global clinical laboratories, which will improve the way patients are tested in advance of treatment. Invest Northern Ireland has offered the company over £480,000 towards its project which is expected to leverage the employment of 20 additional staff at a Diaceutics’ Belfast-based data hub.

Diaceutics is the world’s leading provider of precision medicine data analytics, software and service solutions. The company works with the pharmaceutical industry to further the application of precision medicine, an approach which tailors medical treatments to the individual characteristics of each patient.

Commenting on the investment, Peter Keeling, CEO of Diaceutics, said:”Precision medicine relies on a step change in the way patients are being tested in advance of treatment. High levels of missed and misdiagnosed patients still curtail the promise of precision medicine across the globe and along with the support of Invest NI we will continue to expand our collection, management and analysis of some of the most important patient testing data shaping the precision medicine space today.

“Specifically Invest NI’s support of our research and development work is enabling us to offer a competitive advantage in the marketplace by providing real world evidence, more accurate forecasting and more detailed physician segmentation. We will be working with pharmaceutical firms in the coming months, to build awareness of our advanced insights here and explore opportunities to integrate those insights earlier into their commercial investments.”

Grainne McVeigh, Director of Life Sciences at Invest NI, added:”Diaceutics is undertaking an exciting investment that, through the work with their pharmaceutical clients, will equip physicians with the information and tools to deliver targeted patient care based on their molecular profile, improving outcomes and containing the costs associated with a trial-and-error approach to disease treatment. Life and health science is an area of high growth opportunities and we are delighted to be supporting Diaceutics’ efforts to lead the innovation and commercialisation of solutions that will develop the diagnostics market worldwide.”

Invest NI’s support is part funded by ERDF under the EU Investment for Growth and Jobs Programme 2014-2020. Two of the 20 new positions are already in place.

CAPTION:

Pictured (L-R) are: Grainne McVeigh, Director of Life Sciences, Invest NI; and Peter Keeling, CEO, Diaceutics.

About Author

admin

admin

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4